UK Pharmacy First Scheme: What Quicker Migraine and Acne Treatment Means for Patients

From autumn 2026, patients in England can walk into a participating high street pharmacy and receive treatment for migraine, acne and three other everyday conditions without booking a GP appointment first. The expansion of the UK Pharmacy First scheme, confirmed by NHS England on 10 September 2026, takes the total number of conditions pharmacists can treat to 12 and marks the biggest single widening of community pharmacy clinical services since the scheme launched in January 2024. For anyone who has waited a fortnight for a ten-minute GP slot to treat an ear infection, this is a genuine shift in how primary care works.

The announcement landed on the same day the national flu vaccination booking system opened to the public, giving the NHS two complementary levers to move routine care out of general practice and into community pharmacies before winter pressures bite.

What Is the Pharmacy First Scheme Expansion?

Pharmacy First is an NHS England advanced service that lets pharmacists assess, diagnose and treat specified minor conditions under a clinical pathway, supplying prescription-only medicines where appropriate without a GP consultation. The September 2026 expansion adds five conditions to the existing seven.

The scheme already covered sore throat, earache, sinusitis, impetigo, infected insect bites, shingles and uncomplicated urinary tract infections in women. From autumn, the following are added:

Migraine (acute treatment in adults)
Acne (mild to moderate, in patients aged 12 and over)
Scabies
Ear infections (including recurrent presentations)
One further everyday condition confirmed within the same NHS England announcement

The BBC reported on 10 September 2026 that pharmacies in England will soon offer treatments for a total of 12 common conditions, describing the policy as one designed to save people a trip to the GP first. Crucially, the service is delivered under a national clinical protocol. Pharmacists do not improvise: they follow NHS England pathway criteria, and they refer to general practice or urgent care when a patient falls outside the inclusion criteria.

How the referral and supply model actually works

Under the existing pathway, the patient is assessed in a private consultation room. If they meet the criteria, the pharmacist supplies medicine under a Patient Group Direction or via independent prescribing, and the record is sent to the patient's GP practice. If they do not meet criteria, the pharmacist escalates. This is not a replacement for diagnosis of complex disease: it is triage plus treatment for well-defined, low-risk presentations.

Conditions Covered: Migraines, Acne, Scabies and Ear Infections

The five new conditions were chosen because they are high-volume, low-complexity presentations that consume a disproportionate share of GP appointment time. Around one in seven adults in the UK live with migraine, according to the Migraine Trust, and it remains one of the most common neurological reasons for consulting a GP. Acne is the most common skin condition in adolescents and young adults, and scabies outbreaks have repeatedly stressed dermatology and primary care capacity in recent years, particularly in care settings and student accommodation.

The most underreported element of this expansion is scabies. It is a condition with significant public health implications, it spreads rapidly in shared living environments, and treatment delay prolongs household transmission. Moving first-line treatment into pharmacy removes a bottleneck that has real epidemiological consequences.

What pharmacists can and cannot prescribe under the new pathways

For migraine, the pharmacy pathway focuses on acute management: analgesics, triptans where clinically appropriate, and antiemetics, alongside advice on trigger management and when to seek urgent review for red-flag symptoms. For acne, the focus is mild to moderate presentations suitable for topical retinoids, benzoyl peroxide or topical antibiotics, with referral where there are signs of scarring, nodulocystic disease or hormonal drivers.

Patients presenting with sudden severe headache, neurological deficit, suspected meningitis or first-ever aura with atypical features will be referred, not treated. That distinction matters and it is written into the pathway.

Benefits for Patients: Quicker Access and Convenience

The core patient benefit is time. A pharmacy consultation can typically be delivered on a walk-in or same-day basis, with extended opening hours including evenings and weekends in many locations. For a working parent in Birmingham managing a child's ear infection, or a student in Leeds seeking acne treatment, the practical difference between a two-week GP wait and a same-day pharmacy consultation is substantial.

There is also a cost dimension. An unnecessary GP appointment is not free to the system, and a delayed treatment episode frequently becomes a more expensive one. Conjunctivitis that becomes a corneal problem, or scabies that spreads through a household, both generate downstream NHS costs that dwarf the original consultation.

Social impact: who gains most from pharmacy-first care

The groups that benefit most are precisely those who find general practice hardest to access. People in lower-income households are more likely to lose pay when taking time off for a daytime appointment, and are more likely to rely on urgent care or A&E when routine care is unavailable. According to the British Social Attitudes survey published on 8 September 2026, support for disability benefits remains "remarkably strong," with only about 7% of those polled favouring cuts. That finding sits alongside a broader public expectation that core NHS access should work reliably for people on low incomes.

There is also a geography story. Patients in areas with chronic GP shortages, including parts of coastal England and rural counties, face the longest waits. For them, a pharmacy on the high street is often the only accessible clinical presence in the community. Expanding Pharmacy First is, in effect, a targeted intervention for areas where general practice has been under sustained strain.

Care home residents, people with caring responsibilities, and shift workers also gain disproportionately from same-day pharmacy access, which requires no advance booking and no telephone queue at 8am.

Impact on GPs and the NHS System

General practice in England has been operating under sustained pressure, with millions of appointments each month and a workforce that has not grown in line with demand. Every consultation safely diverted to a pharmacy is a consultation slot released for a patient who genuinely needs a GP: someone with suspected cancer, unexplained weight loss, or a complex multimorbidity review.

The context for this announcement is uncomfortable. BBC analysis published on 10 September 2026 found that cancer care has got worse since the government announced plans to speed up waiting times and save more lives. In other words, the NHS is simultaneously trying to accelerate urgent care and offload routine care. Pharmacy First is the offload mechanism. It will not fix cancer waits, and it is not designed to, but it does protect GP capacity for the patients who most need it.

There is also a digital dimension. The MHRA's chief executive, Lawrence Tallon, told the BBC on 10 September 2026 that the UK needs new laws for AI in healthcare, stating that the technology will soon be routinely used within the NHS. Pharmacy First consultations generate structured clinical data at community level, and that dataset becomes materially more valuable if it can be analysed safely and lawfully. Readers tracking NHS data governance debates, including the controversy over the Palantir contract, can follow our health articles for ongoing coverage.

On the funding side, the scheme operates through the Community Pharmacy Contractual Framework, and the pharmacy sector has consistently argued that the funding envelope has not kept pace with the clinical workload transferred to it. That tension will determine whether expansion translates into genuine capacity, or simply into more unpaid work. For wider context on how public spending pressures affect household and consumer finances, see Baba International.

What the evidence base says about pharmacy-first models

England is not the first mover. Pharmacy First-style models have been running in Scotland and Wales for several years, and the Scottish model, NHS Pharmacy First Scotland, has handled millions of consultations since 2020. The consistent finding across evaluations is that pharmacy-first care is safe for defined minor conditions and highly acceptable to patients, with the main risk being inappropriate supply if pathway criteria are not enforced. NHS England has built audit and antimicrobial stewardship requirements into the service for exactly this reason.

Conclusion: Empowering Pharmacies in Primary Care

The Pharmacy First expansion is the most concrete answer so far to the question of how England delivers routine care when general practice cannot absorb demand. It will not solve NHS waiting lists. It will, for millions of people with migraine, acne, scabies or an ear infection, remove an unnecessary step between feeling unwell and getting treated.

The honest caveat is capacity. If pharmacies are underfunded and understaffed, a new clinical pathway becomes an unfunded mandate. The policy succeeds only if the workforce and the funding follow the announcement.

What You Should Do Now

Check your local pharmacy: not all pharmacies have signed up to deliver every Pharmacy First pathway. Ask in person or check the NHS website's service finder before you travel.
Use the service for the right conditions: migraine, acne, scabies, ear infections, sore throat, sinusitis, impetigo, infected insect bites, shingles and uncomplicated UTIs in women.
Book your flu vaccination now: the national booking system opened on 10 September 2026. Eligible patients can book through their GP, a participating pharmacy, or the NHS App.
Keep your GP informed: pharmacy records are shared with your practice, but for anything recurrent or worsening, book a GP review rather than repeating pharmacy consultations.
Know the red flags: sudden severe headache, vision loss, neurological symptoms, rapidly spreading rash with fever, or suspected sepsis require urgent care, not a pharmacy consultation.
Ask about cost: standard NHS prescription charges apply unless you are exempt. Many Pharmacy First consultations for eligible patients are funded by the NHS, so confirm before treatment.

Baba International Editorial Team

Our editorial team specialises in UK and EU personal finance, health policy, and economic analysis. All content is researched using authoritative sources including the ONS, NHS, Bank of England, ECB, and Eurostat.

Frequently Asked Questions

When does the Pharmacy First expansion start?

NHS England confirmed on 10 September 2026 that pharmacies in England will offer treatment for migraines, acne and three other everyday conditions from autumn 2026. The rollout is phased across participating pharmacies rather than switching on everywhere at once, so availability will vary by location in the first weeks.

Can a pharmacist prescribe migraine medication without seeing my GP?

Yes, for acute migraine treatment in adults who meet the pathway criteria. Pharmacists can supply appropriate acute treatments and provide self-management advice. Patients with atypical symptoms, new neurological signs, or frequent attacks requiring preventive therapy will be referred to a GP.

Do I have to pay for Pharmacy First treatment?

If you are exempt from NHS prescription charges, you pay nothing. If you normally pay, the standard NHS prescription charge applies to any medicine supplied. The consultation itself is funded by the NHS when delivered through the Pharmacy First service.

Is Pharmacy First safe compared with seeing a GP?

For the 12 specified minor conditions, evidence from England, Scotland and Wales shows pharmacy-first assessment is safe and clinically appropriate when pathway criteria are followed. Pharmacists are regulated healthcare professionals, and the service includes mandatory referral criteria and audit requirements. The scheme is deliberately restricted to low-complexity presentations, which is why it does not replace general practice for undiagnosed or complex conditions.

UK Pharmacy First Scheme: What Quicker Migraine and Acne Treatment Means for Patients